26 results on '"Davison, Beth A"'
Search Results
2. Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial
3. Enhanced Decongestive Therapy in Patients With Acute Heart Failure: JACC Review Topic of the Week
4. Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial
5. POINT: Should New Drug Development in Heart Failure Focus on Patients Discharged From an Acute Heart Failure Admission? Lessons From Recent Studies
6. Association of Early Blood Pressure Decrease and Renal Function With Prognosis in Acute Heart Failure
7. Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials
8. Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2
9. Trajectories of Changes in Renal Function in Patients with Acute Heart Failure
10. Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction
11. Serum Potassium Levels and Outcome in Acute Heart Failure (Data from the PROTECT and COACH Trials)
12. Predictors and Associations With Outcomes of Length of Hospital Stay in Patients With Acute Heart Failure: Results From VERITAS
13. Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes: An Exploratory Analysis From the RELAX-AHF Trial
14. Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients With Pre-Cardiogenic Shock
15. Acute Heart Failure in the Elderly: Differences in Clinical Characteristics, Outcomes, and Prognostic Factors in the VERITAS Study
16. Liver Function, In-Hospital, and Post-Discharge Clinical Outcome in Patients With Acute Heart Failure—Results From the Relaxin for the Treatment of Patients With Acute Heart Failure Study
17. Prognostic Significance of ECG Abnormalities for Mortality Risk in Acute Heart Failure: Insight From the Sub-Saharan Africa Survey of Heart Failure (THESUS-HF)
18. Safety Indicators In Patients Receiving High-intensity Care After Acute Heart Failure Admission: The STRONG-HF Trial
19. The Additive Prognostic Value of Serial Plasma Interleukin-6 Levels over Changes in Brain Natriuretic Peptide in Patients with Acute Heart Failure
20. Improvements in Signs and Symptoms During Hospitalization for Acute Heart Failure Follow Different Patterns and Depend on the Measurement Scales Used: An International, Prospective Registry to Evaluate the Evolution of Measures of Disease Severity in Acute Heart Failure (MEASURE-AHF)
21. Symptoms and Signs of Heart Failure at Admission and Discharge and Outcomes in the Sub-Saharan Acute Heart Failure (THESUS-HF) Registry
22. Association between Left Ventricular Ejection Fraction and Worsening Renal Function in Acute Heart Failure: Insights from the RELAX-AHF-2 Trial
23. Failure to Develop New Therapies in Acute Heart Failure—Is It Time to De-focus From Congestion?
24. HETEROGENEITY IN EFFICACY OF ROLOFYLLINE USING A RISK-BASED EVALUATION IN PATIENTS HOSPITALIZED WITH ACUTE HEART FAILURE
25. Prediction of Post-Discharge Outcomes for Patients Hospitalized with Heart Failure: Results from PROTECT
26. Evaluating Treatment Efficacy by Multiple Endpoints in Phase II Acute Heart Failure Clinical Trials: Analyzing Data Using a Global Method
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.